A review of the development of biostatistical design and analysis techniques for assessing in vivo bioequivalence: Part two

Indian Journal of Pharmaceutical Sciences

Volumn 63, Issue 3, 2001, Pages 169-186

  Patterson, Scott ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 10644225653     PISSN: 0250474X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. FDA Guidance. Statistical procedures for bioequivalence studies using a standard two treatment crossover design, 1992, 1.
2. FDA Guidance. Bioavailability and Bioequivalence Studies for Orally Administered Drug Products: General Considerations, 2000b, 1.